A United States appeals court has struck the latest blow in an ongoing battle over the pill mifepristone, often used in medication-induced abortionsOn Wednesday, the three-judge Fifth Circuit Court of Appeals in New Orleans overturned a lower court’s wholesale revocation of the pill’s Food and Drug Administration (FDA) approval.But it kept in place part of the ruling that ends the drug’s availability by mail and limited its use for up to seven weeks of pregnancy, rather than 10. The court’s decision also requires mifepristone to be prescribed by a doctor after an in-person visit.
Load More
Load More